Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D DiMarchi

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Molecular Metabolism|April 17, 2026
GIPR:GCGR co-agonism restores normal weight in obese rodentsDiego Perez-Tilve, Fa Zhang, Yujin Zhang, et al.
Frontiers in Endocrinology|March 18, 2022
Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological ImplicationsYanwu Yang, Michael D Glidden, Balamurugan Dhayalan, et al.
Biochemistry|March 20, 2026
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP ReceptorsFlorence M Brunel, Sebastian D Parlee, Pengyun Li, et al.
Diabetologia|December 21, 2014
GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) miceRobert W Schwenk, Christian Baumeier, Brian Finan, et al.
Molecular Metabolism|May 3, 2017
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female miceSigrid Jall, Stephan Sachs, Christoffer Clemmensen, et al.
Analytical Chemistry|July 31, 2010
Combinatorial libraries of synthetic peptides as a model for shotgun proteomicsBrian C Bohrer, Yong Fuga Li, James P Reilly, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2013
Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cellsRamya S Kuna, Shravan Babu Girada, Suman Asalla, et al.
Experimental Neurology|November 16, 2016
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injuryIan A Tamargo, Miaad Bader, Yazhou Li, et al.
Journal of Diabetes Science and Technology|December 7, 2010
In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effectW Kenneth Ward, Ryan G Massoud, Cory J Szybala, et al.
Cardiovascular Diabetology|August 17, 2023
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic diseaseStephan Sachs, Anna Götz, Brian Finan, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Molecular Metabolism|April 17, 2026
GIPR:GCGR co-agonism restores normal weight in obese rodentsDiego Perez-Tilve, Fa Zhang, Yujin Zhang, et al.
Frontiers in Endocrinology|March 18, 2022
Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological ImplicationsYanwu Yang, Michael D Glidden, Balamurugan Dhayalan, et al.
Biochemistry|March 20, 2026
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP ReceptorsFlorence M Brunel, Sebastian D Parlee, Pengyun Li, et al.
Diabetologia|December 21, 2014
GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) miceRobert W Schwenk, Christian Baumeier, Brian Finan, et al.
Molecular Metabolism|May 3, 2017
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female miceSigrid Jall, Stephan Sachs, Christoffer Clemmensen, et al.
Analytical Chemistry|July 31, 2010
Combinatorial libraries of synthetic peptides as a model for shotgun proteomicsBrian C Bohrer, Yong Fuga Li, James P Reilly, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2013
Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cellsRamya S Kuna, Shravan Babu Girada, Suman Asalla, et al.
Experimental Neurology|November 16, 2016
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injuryIan A Tamargo, Miaad Bader, Yazhou Li, et al.
Journal of Diabetes Science and Technology|December 7, 2010
In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effectW Kenneth Ward, Ryan G Massoud, Cory J Szybala, et al.
Cardiovascular Diabetology|August 17, 2023
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic diseaseStephan Sachs, Anna Götz, Brian Finan, et al.
Pageof 13